NKGN: NKGen Biotech, Inc. Stock

by  •  • Comments Off on NKGN: NKGen Biotech, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 30.56
Enterprise Value ($M) 50.45
Book Value ($M) -58.69
Book Value / Share -2.57
Price / Book -0.52
NCAV ($M) -73.24
NCAV / Share -3.21
Price / NCAV -0.42

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.93
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.05
Current Ratio 0.05

Balance Sheet (mrq) ($M)
Current Assets 1.93
Assets 16.48
Liabilities 75.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -29.75
Net Income -82.95
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -21.95
Cash from Investing -0.05
Cash from Financing 22.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Meteora Capital, LLC 7.30
02-07 13G/A Adage Capital Partners Gp, L.l.c. 0.00
12-19 13D/A NKMAX Co., Ltd. 53.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 ☐ TRANSITION REP
2024-04-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-07 23,430 84,035 27.88
2024-05-06 47,941 122,088 39.27
2024-05-03 51,492 209,580 24.57

(click for more detail)

Similar Companies
NAII – Natural Alternatives International, Inc. NAMS – NewAmsterdam Pharma Company N.V.
NGNE – Neurogene Inc. NRIX – Nurix Therapeutics, Inc.
NTLA – Intellia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io